SVRA Savara Inc
22,764
$4.72
$0.11
(2.28%)
| Watchers | 22,764 |
| 52-Wk Low | $2.46 |
| 52-Wk High | $5.70 |
| Market Cap | $652.25M |
| Volume | 457,624.00 |
| 52-Wk High | $5.70 |
| 52-Wk Low | $2.46 |
Savara Reports First Quarter 2024 Financial Results and Provides Business UpdateBusiness Wire • 7 days ago
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the first quarter ending March 31, 2024 and...
Share to Feed
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the...
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the acceptance of two abstracts for poster presentation at...
This price move could indicate a change in the trend, and may be a sell signal for investors...
This price move could indicate a change in the trend, and may be a buy signal for investors...
This price move could indicate a change in the trend, and may be a sell signal for investors...
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees. On March 21, 2024...
This price move could indicate a change in the trend, and may be a buy signal for investors...
This price move could indicate a change in the trend, and may be a sell signal for investors...
Savara Inc (NASDAQ:SVRA Get Free Report)s stock price fell 5.5% during trading on Monday . The company traded as low as $4.97 and last traded at $5.01. 261,205 shares traded hands...